Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Skyharbour Expands Maverick East Zone with Additional High Grade Uranium Discovered in the .
Skyharbour Resources LtdJanuary 7, 2021 GMT
VANCOUVER, British Columbia, Jan. 07, 2021 (GLOBE NEWSWIRE) Skyharbour Resources Ltd. (TSX-V: SYH)(OTCQB: SYHBF) (Frankfurt: SC1P ) (the “Company”) is pleased to announce the remaining results from its 2020 fall diamond drilling program at its 100% owned, 35,705 hectare Moore Uranium Project, located approximately 15 kilometres east of Denison Mine’s Wheeler River project and proximal to regional infrastructure for Cameco’s Key Lake/McArthur River operations in the Athabasca Basin, Saskatchewan. In addition to the previously announced hole ML20-09 which returned 0.72% U3O8 over 17.5 metres from 271.5 metres to 289.0 metres, drillhole ML20-12 returned another broad zone of sandstone and basement-hosted uranium mineralization from 268.1 metres t
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Merit Medical to Participate in Two Upcoming Investor Conferences
Merit Medical Systems, Inc.January 7, 2021 GMT
SOUTH JORDAN, Utah, Jan. 07, 2021 (GLOBE NEWSWIRE) Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, announced today that it will participate in two upcoming investor conferences.
On Wednesday, January 13, at 2:00 p.m. ET, Fred P. Lampropoulos, President and Chief Executive Officer of Merit, and Raul Parra, Merit’s Chief Financial Officer, will present at the 23rd Annual Needham Growth Conference, which is being held virtually. They will also host virtual one-on-one meetings throughout the day.
Press release content from Business Wire. The AP news staff was not involved in its creation.
ConnectiveRx Strengthens Leadership
WHIPPANY, N.J. (BUSINESS WIRE) Jan 7, 2021
ConnectiveRx, a leading provider of technology-enabled patient support and access solutions for specialty and branded medications, today announced the company is strengthening its leadership to support rapid growth with the appointment of David Wheadon, MD, as member of the company’s board of managers and Jim Corrigan as president.
“David and Jim have exceptional track records for leadership and strategic innovation in the pharmaceutical and greater healthcare sectors,” said ConnectiveRx CEO Harry Totonis. “Their addition to our organization enhances our ability to meet the evolving needs of our pharmaceutical manufacturer partners.”